Current role
Kenneth Truitt, M.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kenneth Truitt, M.D.
Aquestive Therapeutics, Inc. reported in an 8-K filed August 10, 2022 that Kenneth Truitt, M.D. was appointed Chief Medical Officer, effective September 6, 2022.
“On August 10, 2022, the Company announced the appointment of Kenneth Truitt, M.D., as Chief Medical Officer of the Company, effective September 6, 2022.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-09-06–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Aquestive Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Daniel Barber CEO, Board Member
- Gregory B. Brown Chairman
- John S. Cochran Chairman
- A. Ernest Toth CFO
- A. Ernest Toth, Jr. CFO
- Cassie Jung COO
- Thomas A. Zalewski General Counsel
- Abigail L. Jenkins Board Member
- Julie Krop Board Member
- Marco Taglietti Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.